Advanced Cellular Therapeutics (Junior Research Group)
Organisational unit: Research/Working group
Organisation profile
Head of the Research Group: Dr. Anke Fuchs
Related content and researchers (public profile)
- Researchers (public profile)
- Research output
- Journals
- Prizes
- Press/Media
Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity
Santosh Nirmala, S., Kayani, K., Gliwiński, M., Hu, Y., Iwaszkiewicz-Grześ, D., Piotrowska-Mieczkowska, M., Sakowska, J., & 7 othersTomaszewicz, M., Marín Morales, J. M., Lakshmi, K., Marek-Trzonkowska, N. M., Trzonkowski, P., Oo, Y. H. & Fuchs, A., 2023, In: Frontiers in immunology. 14, 1321228.Research output: Contribution to journal › Review article › Contributed › peer-review
DEEP IMMUNE MONITORING OF CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) PATIENTS AFTER REGULATORY T CELL THERAPY
Krishnakumar, K. L. K., Peitzsch, C., Petrera, A., Rost, F., Bonifacio, E., Bornhäuser, M. & Fuchs, A., 2023, In: Cytotherapy. 25, 6, p. S230Research output: Contribution to journal › Research article › Contributed › peer-review
DIFFERENT SOURCES OF POLYOMAVIRUS-SPECIFIC T CELLS AS TREATMENT OPTION FOR JC POLYOMAVIRUS-TRIGGERED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
Morales, J. M., Freund, D., Ruhnke, L., Kretschmann, T., Heidrich, K., Ziemssen, T., Bonifacio, E., & 5 othersvon Bonin, M., Stölzel, F., Schetelig, J., Bornhäuser, M. & Fuchs, A., 2023, In: Cytotherapy. 25, 6Research output: Contribution to journal › Meeting abstract › Contributed › peer-review
IN-DEPTH PHENOTYPING AND FUNCTIONAL CHARACTERIZATION OF REGULATORY T CELLS FROM ADULT PERIPHERAL BLOOD AND CORD BLOOD AS BASIS FOR ADVANCED SUPPRESSIVE CELL THERAPY
Nirmala, S. S., Floegel, F., Eschenbach, A., Winkler, J. L., Birdir, C. & Fuchs, A., 2023, p. S250.Research output: Contribution to conferences › Abstract › Contributed › peer-review
Next Generation Biobanking: Employing a Robotic System for Automated Mononuclear Cell Isolation
Fuchs, Y. F., Brunner, J., Weigelt, M., Schieferdecker, A., Morgenstern, R., Sturm, A., Winter, B., & 11 othersJambor, H., Stölzel, F., Ruhnke, L., von Bonin, M., Rücker-Braun, E., Heidenreich, F., Fuchs, A., Bonifacio, E., Bornhäuser, M., Poitz, D. M. & Altmann, H., 13 Oct 2022, In: Biopreservation and biobanking. 21, 1, 5 p.Research output: Contribution to journal › Research article › Contributed › peer-review
Biopreservation and biobanking
ISSNs: 1947-5535
Additional searchable ISSN (electronic): 1947-5543
Liebert, New Rochelle, NY
Scopus rating (2023): CiteScore 3.3 SJR 0.374 SNIP 0.546
Journal
Cytotherapy
ISSNs: 1465-3249
Additional searchable ISSN (electronic): 1477-2566
Elsevier, New York [u. a.]
Scopus rating (2023): CiteScore 6.3 SJR 1.084 SNIP 0.787
Journal
Frontiers in Immunology
ISSNs: 1664-3224
Additional searchable ISSN (electronic): 1664-3224
Frontiers Media S.A.
Scopus rating (2023): CiteScore 9.8 SJR 1.868 SNIP 1.193
Indexed in DOAJ
Journal
TUD Young Investigator
Fuchs, A. (Recipient), 12 Sept 2023
Prize: Honors › Other Honors/Acknowledgements
4th place in the Science4Life Venture Cup "businessplan phase"
Sieweke, M. (Recipient), Englmeier, L. (Recipient), Fuchs, A. (Recipient) & Bornhäuser, M. (Recipient), 27 Jun 2023
Prize: Innovation/transfer prize
Science4Life - Venture Cup - Business Plan
Fuchs, A. (Recipient) & Englmeier, L. (Recipient), 27 Jun 2023
Prize: Innovation/transfer prize
Science4Life - Venture Cup - Concept Phase
Fuchs, A. (Recipient) & Englmeier, L. (Recipient), 15 Mar 2023
Prize: Innovation/transfer prize
One of the ten winning teams in the Science4Life Venture Cup "concept phase"
Sieweke, M. (Recipient), Englmeier, L. (Recipient), Fuchs, A. (Recipient) & Bornhäuser, M. (Recipient), 14 Mar 2023
Prize: Innovation/transfer prize
Fourth Place for Makrophagen 2.0 at the Science4Life Start-up Competition
Fuchs, A., Sieweke, M. & Englmeier, L.
29 Sept 2023
1 Media contribution
Press/Media
Start-up Project Makrophagen 2.0 One of the Winners of The Concept Phase of the Science4Life Venture Cup
Fuchs, A., Sieweke, M. & Englmeier, L.
22 Mar 2023
1 Media contribution
Press/Media
Life-Saving Cell Therapies From Just Across the Street: CRTD Becomes Production Site for Virus-Specific T Cells for the University Hospital
14 Mar 2023
1 Media contribution
Press/Media
From Lab to Business: CRTD Researchers receive BMBF GO-Bio Initial Funding
Fuchs, A., Sieweke, M. & Englmeier, L.
26 Aug 2022
1 Media contribution
Press/Media